Vanessa Corrales-Agudelo

Dr. Vanessa Corrales-Agudelo

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
JCJuan Jacobo De la Cuesta-Zuluaga
Juan Jacobo De la Cuesta-Zuluaga
NMNoel Mueller
Noel Mueller
RARafael Alvarez-Quintero
Rafael Alvarez-Quintero
EVEliana P. Velásquez-Mejía
Eliana P. Velásquez-Mejía
JRJelver Alexander Sierra Restrepo
Jelver Alexander Sierra Restrepo
Juan EscobarJuan Escobar
Juan Escobar
Fiber fermentation by gut microbiota yields short-chain fatty acids (SCFAs) that are either absorbed by the gut or excreted in feces. Studies are conflicting as to whether SCFAs are beneficial or detrimental to cardiometabolic health, and how gut microbiota associated with SCFAs is unclear. In this study of 441 community-dwelling adults, we examined associations of fecal SCFAs, gut microbiota diversity and composition, gut permeability, and cardiometabolic outcomes, including obesity and hypertension. We assessed fecal microbiota by 16S rRNA gene sequencing, and SCFA concentrations by gas chromatography/mass spectrometry. Fecal SCFA concentrations were inversely associated with microbiota diversity, and 70 unique microbial taxa were differentially associated with at least one SCFA (acetate, butyrate or propionate). Higher SCFA concentrations were associated with a measure of gut permeability, markers of metabolic dysregulation, obesity and hypertension. Microbial diversity showed association with these outcomes in the opposite direction. Associations were significant after adjusting for measured confounders. In conclusion, higher SCFA excretion was associated with evidence of gut dysbiosis, gut permeability, excess adiposity, and cardiometabolic risk factors. Studies assessing both fecal and circulating SCFAs are needed to test the hypothesis that the association of higher fecal SCFAs with obesity and cardiometabolic dysregulation is due to less efficient SCFA absorption.

27 July 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JCJuan Jacobo De la Cuesta-Zuluaga
Juan Jacobo De la Cuesta-Zuluaga
VCVanessa Corrales-Agudelo
Vanessa Corrales-Agudelo
EVEliana P. Velásquez-Mejía
Eliana P. Velásquez-Mejía
JCJenny A. Carmona
Jenny A. Carmona
JAJosé M. Abad
José M. Abad
Juan EscobarJuan Escobar
Juan Escobar
Westernization and its accompanying epidemiological transitions are associated with changes in gut microbiota. While the extremes of this lifestyle spectrum have been compared (hunter-gatherers, industrialized countries), populations undergoing such shifts have received little attention. To fill the gap of knowledge about the microbiome evolution following broad lifestyle changes and the emergence of disease-associated dysbiosis, we performed a cross-sectional study in which we characterized the microbiota of 441 Colombian adults through 16S rRNA gene sequencing and determined its relationship with demographic, health-related and dietary parameters. We showed that in the gut microbiota of this cohort thrive taxa proper of both hunter-gatherers (Prevotella, Treponema) and citizens of industrialized countries (Bacteroides, Bifidobacterium, Barnesiella); the relative abundances of these taxa differed from those in Western and non-Western populations. We also showed that the Colombian gut microbiota is composed of five consortia of co-abundant microorganisms that are differentially associated with lifestyle, obesity and cardiometabolic disease, and highlighted metabolic pathways that might explain associations between microbiota and host health. Our results give insights into the evolution of the gut microbiota, and underscore the importance of this community to human health. Promoting the growth of specific microbial consortia could help ameliorating physiological conditions associated with Western lifestyles.

16 November 2017 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
JCJuan Jacobo De la Cuesta-Zuluaga
Juan Jacobo De la Cuesta-Zuluaga
VCVanessa Corrales-Agudelo
Vanessa Corrales-Agudelo
JCJ A Carmona
J A Carmona
JAJ M Abad
J M Abad
Juan EscobarJuan Escobar
Juan Escobar

25 September 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
AVAngela Sofía Garcia Vega
Angela Sofía Garcia Vega
VCVanessa Corrales-Agudelo
Vanessa Corrales-Agudelo
AMAlejandro Reyes Muñoz
Alejandro Reyes Muñoz
Juan EscobarJuan Escobar
Juan Escobar
Diet plays an important role in shaping gut microbiota. However, much remains to be learned regarding this association. We analyzed dietary intake and gut microbiota in a community-dwelling cohort of 441 Colombians. Diet quality, intake of food groups and nutrient consumption were paired with microbial diversity and composition using linear regressions, Procrustes analyses and a random-forest machine-learning algorithm. Analyses were adjusted for potential confounders, including the five cities from where the participants originated, sex (male, female), age group (18–40 and 41–62 years), BMI (lean, overweight, obese) and socioeconomic status. Microbial diversity was higher in individuals with increased intake of nutrients obtained from plant-food sources, whereas the intake of food groups and nutrients correlated with microbiota structure. Random-forest regressions identified microbial communities associated with different diet components. Two remarkable results confirmed previous expectations regarding the link between diet and microbiota: communities composed of short-chain fatty acid (SCFA) producers were more prevalent in the microbiota of individuals consuming diets rich in fiber and plant-food sources, such as fruits, vegetables and beans. In contrast, an inflammatory microbiota composed of bile-tolerant and putrefactive microorganisms along with opportunistic pathogens thrived in individuals consuming diets enriched in animal-food sources and of low quality, i.e., enriched in ultraprocessed foods and depleted in dietary fiber. This study expands our understanding of the relationship between dietary intake and gut microbiota. We provide evidence that diet is strongly associated with the gut microbial community and highlight generalizable connections between them.

7 September 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
FVFabrice Vaillant
Fabrice Vaillant
VCVanessa Corrales-Agudelo
Vanessa Corrales-Agudelo
NMNatalia Moreno-Castellanos
Natalia Moreno-Castellanos
Alberto Angel-MartinAlberto Angel-Martin
Alberto Angel-Martin
Juan Camilo Henao-RojasJuan Camilo Henao-Rojas
Juan Camilo Henao-Rojas
PPPatrick Poucheret
Patrick Poucheret
Purpose: Golden berry (Physalis peruviana L.) is an exotic fruit exported from Colombia to different countries around the world. A review of the literature tends to demonstrate a hypoglycaemic effect with an improvement in insulin sensitivity after oral ingestion of fruit extracts in animal models. However, little is known about their potential effects in humans, and very little is known about the mechanisms involved. This study aimed at identifying discriminant metabolites after acute and chronic intake of golden berry. Method: An untargeted metabolomics strategy using high-performance chemical isotope-labelling LC-MS was applied. The blood samples of eighteen healthy adults were analysed at baseline, at 6 h after the intake of 250 g of golden berry (acute intervention), and after 19 days of daily consumption of 150 g (medium-term intervention). Results: Forty-nine and 36 discriminant metabolites were identified with high confidence, respectively, after the acute and medium-term interventions. Taking into account up- and downregulated metabolites, three biological networks mainly involving insulin, epidermal growth factor receptor (EGFR), and the phosphatidylinositol 3-kinase pathway (PI3K/Akt/mTOR) were identified. Conclusions: The biological intracellular networks identified are highly interconnected with the insulin signalling pathway, showing that berry intake may be associated with insulin signalling, which could reduce some risk factors related to metabolic syndrome. Primary registry of WHO.

20 April 2026 in medRxiv
Verified
Preprint
Open access
PDF file
Juan EscobarJuan Escobar
Juan Escobar
VCVanessa Corrales-Agudelo
Vanessa Corrales-Agudelo
OOOlga Lucia Ortega-Sierra
Olga Lucia Ortega-Sierra
NVNubia Andrea Villota-Salazar
Nubia Andrea Villota-Salazar
DRDiego A. Rivera
Diego A. Rivera
KMKatalina Muñoz-Durango
Katalina Muñoz-Durango
Obesity and related cardiometabolic diseases pose significant global health challenges. Konjac glucomannan, a soluble dietary fiber, has shown promise in managing these conditions. However, rigorous studies are necessary to establish its benefits on human health. We designed a parallel-arm, triple-blind, placebo-controlled RCT to test the effects of glucomannan (3 g/day, 12 weeks) on body weight and composition, lipid profile, glucose metabolism, inflammation, adipokines, intestinal permeability, gut microbiota, and fecal metabolites in 40 adults. Participants were randomly assigned to either the glucomannan or placebo group, with both groups adhering to personalized hypocaloric diets and moderate physical activity. Outcomes were analyzed as intention-to-treat using linear mixed-effect models. Irrespective of the treatment, our intervention reduced body weight (mean: -2.39 kg; 95% CI: -3.38, -1.40), BMI (−0.83 kg/m 2 ; -1.15, -0.52), and waist (−2.70 cm; -3.87, -1.53). Glucomannan promoted additional benefits not obtained with the placebo, reducing body fat measured by DEXA (body fat%: -2.16%; -3.04, -1.28; VAT: -20.0 cm 2 ; - 29.2, -10.8; FMI: -0.98 kg/m 2 ; -1.34, -0.62), LDL (−14.1 mg/dL; -23.4, -4.9), and the atherogenic index (−0.50; -0.80, -0.21). It also diminished the Framingham score of 10-year risk of coronary heart disease (−0.370; -0.625, -0.115), C reactive protein (−1.01 mg/L; -2.18, 0.15), leptin (−2.06 ng/mL; -4.48, 0.365), and leptin/adiponectin (−0.282; -0.603, 0.040). The two treatments had similar intakes, physical activity, and adherence to the intervention. There were no adverse effects. This intervention fostered health benefits in a population at high risk of cardiometabolic diseases. Konjac glucomannan was an effective co-adjuvant for further reducing risk factors.